Since ABCB1 has been shown to represent an important factor for multiple drug resistance [3], the finding that the FKBP5/AR/ABCB1 axis plays a role in txr in ovarian cancer cells supports the usefulness of our strategy. This evidence concerns the gene ABCB1 and ovarian carcinoma.